Csk Biocare Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 13.05%
- Profit Growth 74.62%
- Ebitda -164.44%
- Net Worth -6.83%
- Total Assets 32.11%
About Csk Biocare
Csk Biocare Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 2019 (Five years and nine months 10 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Deepika Mulpuri, Sirisha Chavalam, and Chandana Sahoo serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2019PTC132285
-
Company No.
132285
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Apr 2019
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Csk Biocare Private Limited offer?
Csk Biocare Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Pharmaceutical Excipients.
Who are the key members and board of directors at Csk Biocare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepika Mulpuri
|
Director | 25-Apr-2019 | Current |
|
Sirisha Chavalam
|
Director | 25-Apr-2019 | Current |
|
Chandana Sahoo
|
Director | 25-Apr-2019 | Current |
Financial Performance of Csk Biocare.
Csk Biocare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.05% increase. The company also saw a substantial improvement in profitability, with a 74.62% increase in profit. The company's net worth dipped by a decrease of 6.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Csk Biocare?
Unlock access to Csk Biocare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Csk Biocare?
Unlock and access historical data on people associated with Csk Biocare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Csk Biocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Csk Biocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.